Synthaverse S.A. (WSE:SVE)
4.065
-0.035 (-0.85%)
Nov 3, 2025, 2:42 PM CET
Synthaverse Market Cap
Synthaverse has a market cap or net worth of 286.62 million as of November 3, 2025. Its market cap has decreased by -6.67% in one year.
Market Cap
286.62M
Enterprise Value
375.98M
Revenue
71.76M
Ranking
n/a
PE Ratio
64.14
Stock Price
4.07
Market Cap Chart
Since July 29, 2011, Synthaverse's market cap has increased from 144.00M to 286.62M, an increase of 99.04%. That is a compound annual growth rate of 4.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 290.16M | -8.65% |
| Dec 30, 2024 | 317.63M | 5.87% |
| Dec 29, 2023 | 300.01M | -28.71% |
| Dec 30, 2022 | 420.86M | 45.25% |
| Dec 30, 2021 | 289.76M | -48.06% |
| Dec 30, 2020 | 557.85M | 753.33% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.24B |
| NEUCA | 3.34B |
| Synektik Spólka Akcyjna | 2.24B |
| Voxel | 1.60B |
| Celon Pharma | 1.16B |
| Selvita | 677.32M |
| Centrum Medyczne ENEL-MED | 511.87M |
| Bioceltix | 477.67M |